Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS at Natera, Inc. (NTRA), sold 2,214 shares at $260.49 ($569K) on 2026-07-27, disclosed to the SEC on 2026-07-29.
Scheduled sale ($569k) by PRESIDENT, CLINICALDIAGNOSTICS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $260.49 | 1,010 | $263K | 46.2% |
| 2 | $254.07 | 1,204 | $306K | 53.8% |
| Total | $257.00 avg | 2,214 | $569K | 100% |
| Filing → |
| NTRA | SELL | 2026-08-05 | $906K | — | Filing → |
| NTRA | SELL | 2026-07-06 | $819K | — | Filing → |
| NTRA | SELL | 2026-06-03 | $655K | — | Filing → |